Navigation Links
Daktari Accepted into WHO Prequalification of Diagnostics Programme
Date:7/18/2014

CAMBRIDGE, Mass., July 18, 2014 /PRNewswire/ -- Daktari Diagnostics is pleased to announce the acceptance of the Daktari CD4 Instrument into the Prequalification of Diagnostics Programme within the World Health Organization (WHO). The Daktari CD4 is a portable and wirelessly connected point-of-care diagnostic platform that can deliver a patient's CD4 cell count in less than 15 minutes, all from a single drop of blood.

The Daktari CD4 is geared toward resource-limited settings and is the first of Daktari's point-of-care technologies to enter the commercialization phase.

Facilitated through the Diagnostics and Laboratory Technology Team (DLT) within the department of Essential Health Technologies (EHT), the goal of the WHO Prequalification of Diagnostics program is to encourage and simplify access to safe, inexpensive, and high quality diagnostic devices intended to address the most pressing global diseases. As part of the WHO Prequalification of Diagnostics Programme, the Daktari CD4 will undergo extensive and thorough evaluation in hopes of receiving prequalification status of diagnostics. If approved, the Daktari CD4 will be eligible for procurement in United Nations' tenders.

"We are thrilled that the Daktari CD4 has been accepted into the WHO Prequalification of Diagnostics Programme," said Betsy Wonderly, Daktari's Global Product Manager. "Our team has been working incredibly hard day in and day out to bring the Daktari CD4 to those who need it the most, and being a part of the Prequalification of Diagnostics Programme is a big step forward in achieving that goal."

About WHO

WHO is the primary authority for health as part of the United Nations, where its main focus is to offer guidance and direction on global health issues by developing the health research agenda, declaring global health benchmarks, communicating policy options, delivering support to countries and keeping up with global health trends. WHO is governed by The World Health Assembly, which is made up of representatives from 194 Member States. The World Health Assembly meets once each year in Geneva to discuss and solidify guidelines.

About Daktari

Daktari Diagnostics, Inc. (www.daktaridx.com) is a venture-backed company based in Cambridge, USA. Daktari's corporate mission is to address the world's biggest health problems by building a market-leading business around a fleet of accurate, portable diagnostic products that can be deployed anywhere in the world. The Daktari technology platform combines electrochemical sensing with microfluidics, enabling highly accurate, low-cost diagnostics in a handheld format. The Daktari connectivity platform provides seamless data management for results produced at any health facility.

Media Contact

Betsy Wonderly
Daktari Diagnostics
media@daktaridx.com
+1 (617) 336-3299

Photo - http://photos.prnewswire.com/prnh/20140325/NE90169-a
Logo - http://photos.prnewswire.com/prnh/20140325/NE90169LOGO-b


'/>"/>
SOURCE Daktari Diagnostics, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. New Drug Application For Naloxegol Accepted By United States Food And Drug Administration
2. Micell Technologies Announces DESSOLVE I Manuscript Accepted for Publication in American College of Cardiologys Cardiovascular Interventions Journal
3. New Drug Application Filing for Ibrutinib Accepted in Two B-cell Malignancies by the U.S. FDA
4. Actavis NDA for Progestin-Only Patch Accepted for Filing by FDA
5. Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA
6. Anthera Announces the Phase 2b PEARL-SC Data Has Been Accepted as a Late Breaking Poster Presentation at the ACR/ARHP 2012 Annual Scientific Meeting
7. CardioChek Test System Accepted by HEART UK for Use in Nationwide Program
8. Beckman Coulter to Acquire Siemens Healthcare Diagnostics Clinical Microbiology Business
9. Decline in Prescription Drug Misuse More than Twice as High in States with Broad Drug Abuse Prevention Programs, New Quest Diagnostics Health Trends Study Finds
10. Diagnostics Market in Transition--Amid Regulatory Uncertainty and Intensifying Competition
11. Diomics Announces Issuance Of U.S. Patents For Novel Biologic Sample DNA Collection Materials For Use In Forensics And Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... MOUNTAIN VIEW, Calif. , June 23, 2016 ... 9:00 a.m. CST on Thursday, July 7, 2016 , , ... kayla.belcher@frost.com ) , , , , EXPERT PANELISTS:  ... Sciences, Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, ... The global pharmaceutical industry is witnessing ...
(Date:6/23/2016)... , June 23, 2016 The vast ... an outpatient dialysis facility.  Treatments are usually 3 times ... hours per visit, including travel time, equipment preparation and ... patient, but especially grueling for patients who are elderly ... a skilled nursing and rehabilitation centers for some duration ...
Breaking Medicine Technology:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... ... 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can ... CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn ... X . Simply select a ProHand generator and drag it above media or text ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
Breaking Medicine News(10 mins):